Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5,10, and 20 mg) in Adults with Major Depressive Disorder

Project: Research

Project Details

StatusFinished
Effective start/end date07/15/15 → 07/14/20

Funding

  • Takeda Development Center Americas Incorporated: $17,162.10